Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Healthcare Biotechnology
Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more

TSX:MSCL - Post Discussion

Satellos Bioscience Inc > .018 per share pre-consolidation nice
View:
Post by Drambuey on Jul 13, 2022 5:07pm

.018 per share pre-consolidation nice

What a joke this company is, azzclowns running this POS.
Comment by IFlyTheUnicorn on Jul 14, 2022 12:16am
This post has been removed in accordance with Community Policy
Comment by Itistoo on Jul 14, 2022 7:48pm
Sure has been, market isn't helping right now but it really didn't seem like they were ready to go public and overestimated peoples interest in the company. Feels like its at the bottom right now but you never know. Should have sold right after the merger
Comment by G1945V on Jul 15, 2022 8:05am
Let's see what the preliminary short form prospectus will bring forth, if it does close on July 28, 2022?  G1945V
Comment by beenthere on Jul 17, 2022 7:41am
And they didn't even last a year before they start diluting us! Unreal!
Satellos Bioscience Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities